Abstract
Hematoporphyrin derivative accumulates in malignant brain tumors and, when activated by light, can produce a cytotoxic reaction. A system for utilizing this concept in the treatment of human malignant brain tumors has been developed and tested in a small series of patients. No significant adverse reactions have occurred, and further development and research are planned.
Original language | English (US) |
---|---|
Pages (from-to) | 672-678 |
Number of pages | 7 |
Journal | Unknown Journal |
Volume | 9 |
Issue number | 6 |
DOIs | |
State | Published - Jan 1 1981 |
Externally published | Yes |
ASJC Scopus subject areas
- Surgery
- Clinical Neurology